"O Hospital CUF Porto disponibiliza uma vasta oferta de cuidados de saúde para toda a família. Consulte os serviços e faça a sua marcação online."

During the past decade, Hospital Cuf porto conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Cuf porto" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Cochlear" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Cuf porto" #1 collaborator was "BeiGene" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Icad, Inc." with 1 trials as a collaborator, "LivaNova" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Cuf porto" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced Cholangiocarcinoma" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Ductal Carcinoma in Situ" (1 trials) and "FGFR2 Gene Rearrangements" (1 trials). Many other conditions were trialed in "Hospital Cuf porto" in a lesser frequency.

Most popular intervention types in "Hospital Cuf porto" are "Drug" (12 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cisplatin" (2 trials), "Pemetrexed" (2 trials), "Amivantamab" (1 trials) and "Anti PD-1/L1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Cuf porto" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Cuf porto". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Cuf porto, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Cuf porto, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".